Adjacent-level disease after fusion: deciding whether another operation is needed
An MRI report mentioning degeneration beside an old spinal fusion does not automatically mean that another operation is needed. The first question is whether that level explains a new clinical problem. This matters particularly when the original operation helped and a later report makes it sound as though the whole reconstruction has failed.
A neighbouring change is not the same as a failed fusion
Mayfield Brain & Spine describes degeneration above or below a fused segment and notes that both ageing and altered mechanics may contribute. It also acknowledges uncertainty about their relative roles. A change on a later scan therefore cannot, by itself, establish that the earlier operation was unnecessary or incorrectly performed.
Keep three questions separate: has the fused segment healed, is the neighbouring segment altered, and which finding is responsible for current symptoms? These questions can produce different answers. A reviewer who uses the phrase “adjacent segment disease” should explain what clinical evidence makes the adjacent finding relevant in your case.
Describe what changed after the best period of recovery
A clear timeline is more useful than a stack of undated reports. Note which symptoms improved after surgery, which remained and when the current difficulty began. A new limitation in walking, a different distribution of arm or leg symptoms, or a change in daily function deserves its own description rather than being grouped under “back pain again”.
Include the operation date, the treated levels and any subsequent procedures. The earlier operative report and implant details help the receiving team understand what is already present. If old images cannot be obtained, say so; a missing baseline should not be replaced by guesses about how the spine looked before the operation.
Compare a plan for symptoms with a plan for images
Mayfield describes nonsurgical treatment as part of the assessment and treatment pathway for many patients with this problem. Its suitability depends on the current neurological situation. Observation should have a purpose and a review point; surgery should have a defined target. Neither approach is adequately explained by saying that the scan simply “looks worn”.
For a stable problem, request a written description of what would count as improvement, what would trigger reassessment and who will follow the changes. This makes continued treatment easier to evaluate. It also gives a second specialist a clearer basis for deciding whether the first plan has been given a reasonable trial.
If extension of the fusion is proposed
Spinal fusion joins vertebrae to prevent movement at the treated segment, as AAOS explains. Extending an existing fusion therefore needs its own rationale. Ask whether the intended benefit comes from releasing pressure, stabilising the adjacent segment, correcting alignment or a combination of tasks. The answer should connect to the actual problem documented during assessment.
It is also useful to know which old components would remain and which might need changing. A previous implant does not automatically require complete replacement. Conversely, a short-sounding addition can still involve revision work that is absent from a first-time operation. The medical plan should make that distinction before the quote is compared.
Keep urgent change outside the travel timetable
New marked weakness or loss of bladder or bowel control needs urgent local assessment. Do not treat a request for another overseas opinion as permission to wait. When the situation is stable enough for a consultation in Turkey, agree what question the visit should resolve and which earlier records the surgeon still needs.
The most useful result is a reasoned explanation of the present symptoms and the next decision. It may support another operation, further assessment or continued observation. It should not make an incidental neighbouring change sound like an inevitable series of future surgeries.
Sources
Medicina Turkey patient information. General guidance; individual medical decisions should be discussed with the treating clinician.